Your browser doesn't support javascript.
loading
Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole.
Umehara, Hiroshi; Maekawa, Yoshimi; Koizumi, Fumito; Shimizu, Makiko; Ota, Toshio; Fouad, Tamer M; Willey, Jie; Kaito, Hidekuni; Shiraishi, Norihiko; Nakashima, Daisuke; Akinaga, Shiro; Ueno, Naoto T.
Afiliación
  • Umehara H; Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd, Shizuoka, Japan.
  • Maekawa Y; Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd, Shizuoka, Japan.
  • Koizumi F; Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd, Shizuoka, Japan.
  • Shimizu M; Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd, Shizuoka, Japan.
  • Ota T; Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd, Shizuoka, Japan.
  • Fouad TM; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Willey J; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kaito H; Fujifilm Kyowa Kirin Biologics Co., Ltd., Galashiels, UK.
  • Shiraishi N; R&D Division, Kyowa Hakko Kirin Co., Ltd, Tokyo, Japan.
  • Nakashima D; R&D Division, Kyowa Hakko Kirin Co., Ltd, Tokyo, Japan.
  • Akinaga S; R&D Division, Kyowa Hakko Kirin Co., Ltd, Tokyo, Japan.
  • Ueno NT; Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, Texas 77030, USA.
Ther Adv Med Oncol ; 10: 1758835918786858, 2018.
Article en En | MEDLINE | ID: mdl-30083253

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2018 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2018 Tipo del documento: Article País de afiliación: Japón